Mild to Moderate Alzheimers
STUDY DETAILS
Mild to moderate Alzheimer's study.
Marlton, NJ
Up to $10300
Approx 27 visits, 19 overnight stays, 8 OP visits
Male/Female
Age 50 - 80
Smoker / Non Smoker
Mild Cognitive Impairment (MCI)
157048
We are looking for men or nonfertile women of at least 50 years of age with mild to moderate Alzheimer's. You must have been on stable medications for 2 months and be willing to undertake an MRI scan.
You will be compensated as follows:
Patient: $100-$900 per visit including MRI's, PET scans, and LP's
Caregiver: $100-$850 per visit MRI's, PET scans, and LP's
What does the study involve?
- Approx 27 visits
- 19 overnight stays
- 8 Outpatient visits
- MRI scans
- PET scans
Who can participate?
- Male/Female
- Age 50 - 80
- Women must be nonfertile.
- Stable medications for 2 months.
- Willing to do MRI scan
How much can I get paid?
The amount you can get paid varies by study and time involved. If you meet the requirements to participate in the clinical trial and are selected to enroll, the payment terms (how much and how often) will be explained to you during the consenting process. Payment is also based on whether you complete all visits and procedures in the study.
What is a clinical study?
Clinical studies (also called clinical trials or clinical research) are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical studies are the fastest and safest way to find treatments that work – and they are only possible with the help of participants like you.
Related Studies
Get in Touch
ADDRESS
PRA Health Sciences
401 Route 73 North
30 Lake Center Executive Park
Suite 100
Marlton, NJ 08058
PHONE NUMBER
(844) 772-7465
(844) 772-7465
Frequently Asked Questions
No FAQs now
Meet some of our extraordinary people and discover what PRA means to them!
About PRA Health Sciences
We’re committed to the drug development process because we understand how it impacts the lives of patients and their families. At the end of the day, we’re not just researchers. We’re patients. We’re survivors. We’re family members.